Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Long-term Maintenance of =50% Migraine Response with Eptinezumab Treatment in Patients with 2–4 Prior Preventive Migraine Treatment Failures

              Author:Ailani, Jessica   Soni-Brahmbhatt, Seema   Awad, Susanne   Lee, Xin Ying   Sperling, Bjorn   Lipton, Richard B.   

              Session Name:S22: Advances in Migraine and Therapeutics  

              Topic:Headache  

              Program Number:S22.008  

              Author Institution:Georgetown University Hospital, Washington, DC  Lundbeck LLC, Deerfield, IL  H. Lundbeck A/S, Copenhagen, Denmark  Albert Einstein College of Medicine, Bronx, NY  

              Impact of Psychiatric Conditions on the Real-world Effectiveness of Eptinezumab Treatment in Patients with Chronic Migraine

              Author:Argoff, Charles   Herzog, Steven   Smith, Ryan   Soni-Brahmbhatt, Seema   Awad, Susanne   Asher, Divya   Khan, Fawad   

              Session Name:P4: Headache in the Real World  

              Topic:Headache  

              Program Number:P4.005  

              Author Institution:Albany Medical Center, Albany, NY  Texas Neurology, Dallas, TX  St Luke's Clinic, Meridian, ID  Lundbeck LLC, Deerfield, IL  H. Lundbeck A/S, Copenhagen, Denmark  The McCasland Family Comprehensive Headache Center, Ochsner Neurosciences Institute, New Orleans, LA  

              Shift in MHDs below the threshold of preventive optimization after eptinezumab treatment in patients with migraine and history of 2–4 preventive migraine treatment failures

              Author:Starling, Amaal   Asher, Divya   Awad, Susanne   Lee, Xin Ying   Goadsby, Peter   Sperling, Bjorn   

              Session Name:P5: Headache: Advances in CGRP Inhibition 1  

              Topic:Headache  

              Program Number:P5.010  

              Author Institution:Mayo Clinic, Scottsdale, AZ  Lundbeck LLC, Deerfield, IL  H. Lundbeck A/S, Copenhagen, Denmark  University of California, Los Angeles, Los Angeles, CA  

              Real-world Effectiveness of Intravenous Eptinezumab in Patients with Chronic Migraine and Previous Subcutaneous Preventive Migraine Treatment

              Author:Argoff, Charles   Herzog, Steven   Smith, Ryan   Soni-Brahmbhatt, Seema   Awad, Susanne   Asher, Divya   Khan, Fawad   

              Session Name:P8: Headache: Advances in CGRP Inhibition 2  

              Topic:Headache  

              Program Number:P8.004  

              Author Institution:Albany Medical Center, Albany, NY  Texas Neurology, Dallas, TX  St Luke's Clinic, Meridian, ID  Lundbeck LLC, Deerfield, IL  H. Lundbeck A/S, Copenhagen, Denmark  The McCasland Family Comprehensive Headache Center, Ochsner Neurosciences Institute, New Orleans, LA  

              Effects of Brexpiprazole on Agitation Associated with Dementia Due to Alzheimer’s Disease: Analysis of Pooled Response Data from Two Phase 3 Fixed-dose Trials

              Author:Behl, Saloni   Lee, Daniel   Aggarwal, Jyoti   Hefting, Nanco   Chen, Dalei   Chang, Denise   

              Session Name:P9: Dementia and Behavioral Neurology: Treatments 1  

              Topic:Aging, Dementia, Cognitive, and Behavioral Neurology  

              Program Number:P9.018  

              Author Institution:Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ  H. Lundbeck A/S, Copenhagen, Denmark  Otsuka Pharmaceutical Development & Commercialization Inc., Berkeley Heights, NJ